PsyMed Ventures invests in frontier technology for brain and mental health, from neurotech and BCI to digital health, precision neuroscience and novel therapeutics. It was co-founded by Matias Serebrinsky, former head of NVIDIA Inception North America, and Greg Kubin, and has backed Delix Therapeutics, Motif Neurotech and Remepy.